Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | KDM6A | O15550 | 1/20 | 1.00 |
| ▸ | KDM4A | O75164 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | KDM5C | P41229 | 1/20 | 1.00 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 1.00 |
| ▸ | DOHH | Q9BU89 | 1/20 | 1.00 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 1.00 |
| ▸ | COMT | P21964 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | APP | P05067 | 3/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP7 | P09237 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deferiprone SCHEMBL20775057 | 1.00 | KDM4E (1.00) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL692741 | 0.98 | KDM4E (0.96) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL10464107 | 0.98 | KDM4E (0.96) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL28363784 | 0.98 | KDM4E (0.96) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL28405012 | 0.87 | KDM4E (0.76) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL28536949 | 0.87 | KDM4E (0.76) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL6400926 | 0.87 | KDM4E (0.76) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL7224598 | 0.82 | KDM4E (0.67) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL4951162 | 0.80 | KDM4E (0.65) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL9075381 | 0.79 | KDM4E (0.63) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9154 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144779-A1 | MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE | CHIESI FARMACEUTICI S.P.A. (IT) | 2026-05-28 | — | — | US | claimed |
| US-20260146046-A1 | BICYCLIC FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2026-05-28 | — | — | US | claimed |
| CN-122080099-A | Amphiphilic nicotinamide adenine dinucleotide conjugate, nano micelle and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-121628980-B | Quantum dot synthesized by cell in-situ programming, and preparation method and application thereof | 南开大学 | 2026-05-22 | — | — | CN | claimed |
| EP-4097881-B1 | COMMUNICATION DEVICES AND METHODS FOR ITERATIVE CODE DESIGN | HUAWEI TECH CO LTD (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-3364967-B1 | FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2026-05-20 | — | — | EP | claimed |
| WO-2026098092-A1 | MOTOR-RELATED ELECTROENCEPHALOGRAPHIC SIGNAL SOURCE LOCALIZATION METHOD AND SYSTEM BASED ON MNE-GAN | 东南大学 | 2026-05-15 | — | — | WO | claimed |
| US-20260132772-A1 | PANORAMIC STITCHING METHOD FOR INFRARED IMAGES OF WIND TURBINE BLADE, DEVICE, STORAGE MEDIUM, AND PRODUCT | HUNAN UNIV (CN) | 2026-05-14 | — | — | US | claimed |
| EP-4739300-A1 | MODULATORS OF IRON METABOLISM FOR TREATING CONDITIONS ASSOCIATED WITH CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2026-05-13 | — | — | EP | claimed |
| US-20260130112-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2026-05-07 | — | — | US | claimed |
| WO-1990003840-A1 | METHOD AND APPARATUS FOR CONTINUOUS CHEMICAL REACTIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1990-04-19 | — | — | WO | claimed |
| US-4840958-A | Novel 3-hydroxypyrid-2-ones and 3-hydroxyprid-4-ones useful in treating patients having a toxic concentration of iron | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1989-06-20 | — | — | US | claimed |
| EP-0313305-A2 | Photoprotection compositions comprising chelating agents | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | claimed |
| EP-0093498-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING N-SUBSTITUTED-3-HYDROXYPYRID-2-ONE OR -4-ONE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-11-26 | — | — | EP | claimed |
| EP-0094149-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING A COMPLEX OF IRON WITH N-SUBSTITUTED 3-HYDROXYPYRID-2-ONE OR -4-ONE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-09-10 | — | — | EP | claimed |
| US-4550101-A | Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1985-10-29 | — | — | US | claimed |
| EP-0159194-A2 | Iron 3-hydroxypyrone or 3-hydroxypyridone complexes and pharmaceutical compositions containing them | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1985-10-23 | — | — | EP | claimed |
| EP-0145228-A1 | Pharmaceutical compositions | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1985-06-19 | — | — | EP | claimed |
| EP-0094149-A2 | Pharmaceutical compositions containing a complex of iron with N-substituted 3-hydroxypyrid-2-one or -4-one derivatives | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1983-11-16 | — | — | EP | claimed |
| EP-0093498-A2 | Pharmaceutical compositions containing N-substituted-3-hydroxypyrid-2-one or -4-one derivatives | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1983-11-09 | — | — | EP | claimed |